Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 306

1.

Development and Validation of HPLC Analytical Method for Chlorantraniliprole in Bulk and in the Formulation.

Kapupara PP, Sorathiya V, Patel RP, Shah KV.

Folia Med (Plovdiv). 2018 Mar 1;60(1):133-140. doi: 10.1515/folmed-2017-0071.

PMID:
29668443
2.

Nuts and Bolts of Oil and Temperature in Topical Preparations of Salicylic Acid.

Ashara KC, Shah KV.

Folia Med (Plovdiv). 2017 Sep 1;59(3):279-288. doi: 10.1515/folmed-2017-0034.

PMID:
28976900
3.

Association of Permeability and Lipid Content of Membrane.

Ashara KC, Shah KV.

Folia Med (Plovdiv). 2017 Jun 1;59(2):203-209. doi: 10.1515/folmed-2017-0019.

PMID:
28704191
4.

Emulsion of Chloramphenicol: an Overwhelming Approach for Ocular Delivery.

Ashara KC, Shah KV.

Folia Med (Plovdiv). 2017 Mar 1;59(1):23-30. doi: 10.1515/folmed-2017-0007.

PMID:
28384103
5.

Recommendations for screening and early detection of common cancers in India.

Rajaraman P, Anderson BO, Basu P, Belinson JL, Cruz AD, Dhillon PK, Gupta P, Jawahar TS, Joshi N, Kailash U, Kapambwe S, Katoch VM, Krishnan S, Panda D, Sankaranarayanan R, Selvam JM, Shah KV, Shastri S, Shridhar K, Siddiqi M, Sivaram S, Seth T, Srivastava A, Trimble E, Mehrotra R.

Lancet Oncol. 2015 Jul;16(7):e352-61. doi: 10.1016/S1470-2045(15)00078-9. Review.

PMID:
26149887
6.

Using implementation science to advance cancer prevention in India.

Krishnan S, Sivaram S, Anderson BO, Basu P, Belinson JL, Bhatla N, D'Cruz A, Dhillon PK, Gupta PC, Joshi N, Jhulka PK, Kailash U, Kapambwe S, Katoch VM, Kaur P, Kaur T, Mathur P, Prakash A, Sankaranarayanan R, Selvam JM, Seth T, Shah KV, Shastri S, Siddiqi M, Srivastava A, Trimble E, Rajaraman P, Mehrotra R.

Asian Pac J Cancer Prev. 2015;16(9):3639-44. Review.

7.

Acute kidney injury, hyperbilirubinemia, and ischemic skin necrosis due to massive sulindac overdose.

Vaughn JL, Shah KV, Ghossein MM, Meyer WL, Kirkpatrick RB.

Curr Drug Saf. 2015;10(2):190-2.

PMID:
25986039
8.

Hemodynamic Characterization of a Mouse Model for Investigating the Cellular and Molecular Mechanisms of Neotissue Formation in Tissue-Engineered Heart Valves.

James IA, Yi T, Tara S, Best CA, Stuber AJ, Shah KV, Austin BF, Sugiura T, Lee YU, Lincoln J, Trask AJ, Shinoka T, Breuer CK.

Tissue Eng Part C Methods. 2015 Sep;21(9):987-94. doi: 10.1089/ten.TEC.2015.0011. Epub 2015 May 29.

9.

Transplantation of pulmonary valve using a mouse model of heterotopic heart transplantation.

Lee YU, Yi T, James I, Tara S, Stuber AJ, Shah KV, Lee AY, Sugiura T, Hibino N, Shinoka T, Breuer CK.

J Vis Exp. 2014 Jul 23;(89). doi: 10.3791/51695.

10.

Dense genotyping of immune-related loci identifies variants associated with clearance of HPV among HIV-positive women in the HIV epidemiology research study (HERS).

Sudenga SL, Wiener HW, King CC, Rompalo AM, Cu-Uvin S, Klein RS, Shah KV, Sobel JD, Jamieson DJ, Shrestha S.

PLoS One. 2014 Jun 11;9(6):e99109. doi: 10.1371/journal.pone.0099109. eCollection 2014. Erratum in: PLoS One. 2014;9(7):e102728.

11.
12.

Acceptability of HPV vaccine implementation among parents in India.

Paul P, Tanner AE, Gravitt PE, Vijayaraghavan K, Shah KV, Zimet GD, Study Group C.

Health Care Women Int. 2014;35(10):1148-61. doi: 10.1080/07399332.2012.740115. Epub 2013 Apr 23.

13.

Kyasanur forest disease virus: viremia and challenge studies in monkeys with evidence of cross-protection by Langat virus infection.

Shah KV, Dandawate CN, Bhatt PN.

F1000Res. 2012 Dec 7;1:61. doi: 10.12688/f1000research.1-61.v1. eCollection 2012.

14.

Bacterial vaginosis and the natural history of human papillomavirus.

King CC, Jamieson DJ, Wiener J, Cu-Uvin S, Klein RS, Rompalo AM, Shah KV, Sobel JD.

Infect Dis Obstet Gynecol. 2011;2011:319460. doi: 10.1155/2011/319460. Epub 2011 Aug 16.

15.

JC virus antibody and viremia as predictors of progressive multifocal leukoencephalopathy in human immunodeficiency virus-1-infected individuals.

Viscidi RP, Khanna N, Tan CS, Li X, Jacobson L, Clifford DB, Nath A, Margolick JB, Shah KV, Hirsch HH, Koralnik IJ.

Clin Infect Dis. 2011 Oct;53(7):711-5. doi: 10.1093/cid/cir507. Epub 2011 Aug 18.

16.

Shedding of Epstein-Barr virus and cytomegalovirus from the genital tract of women in a periurban community in Andhra Pradesh, India.

Silver MI, Paul P, Sowjanya P, Ramakrishna G, Vedantham H, Kalpana B, Shah KV, Gravitt PE.

J Clin Microbiol. 2011 Jul;49(7):2435-9. doi: 10.1128/JCM.02206-10. Epub 2011 Apr 27.

17.

Guidelines for biosafety laboratory competency: CDC and the Association of Public Health Laboratories.

Delany JR, Pentella MA, Rodriguez JA, Shah KV, Baxley KP, Holmes DE; Centers for Disease Control and Prevention.

MMWR Suppl. 2011 Apr 15;60(2):1-23.

PMID:
21490563
18.

Looking ahead: a case for human papillomavirus testing of self-sampled vaginal specimens as a cervical cancer screening strategy.

Gravitt PE, Belinson JL, Salmeron J, Shah KV.

Int J Cancer. 2011 Aug 1;129(3):517-27. doi: 10.1002/ijc.25974. Review.

19.

HPV testing for cervical cancer screening appears more cost-effective than Papanicolau cytology in Mexico.

Flores YN, Bishai DM, Lorincz A, Shah KV, Lazcano-Ponce E, Hernández M, Granados-García V, Pérez R, Salmerón J.

Cancer Causes Control. 2011 Feb;22(2):261-72. doi: 10.1007/s10552-010-9694-3. Epub 2010 Dec 18.

20.

Indian women with higher serum concentrations of folate and vitamin B12 are significantly less likely to be infected with carcinogenic or high-risk (HR) types of human papillomaviruses (HPVs).

Piyathilake CJ, Badiga S, Paul P, Vijayaraghavan K, Vedantham H, Sudula M, Sowjanya P, Ramakrishna G, Shah KV, Partridge EE, Gravitt PE.

Int J Womens Health. 2010 Aug 9;2:7-12.

21.

Effectiveness of VIA, Pap, and HPV DNA testing in a cervical cancer screening program in a peri-urban community in Andhra Pradesh, India.

Gravitt PE, Paul P, Katki HA, Vendantham H, Ramakrishna G, Sudula M, Kalpana B, Ronnett BM, Vijayaraghavan K, Shah KV; CATCH Study Team.

PLoS One. 2010 Oct 28;5(10):e13711. doi: 10.1371/journal.pone.0013711.

22.

An unusual presentation of immotile-cilia syndrome with azoospermia: Case report and literature review.

Dixit R, Dixit K, Jindal S, Shah KV.

Lung India. 2009 Oct;26(4):142-5. doi: 10.4103/0970-2113.56352.

23.

Determinants of VIA (Visual Inspection of the Cervix After Acetic Acid Application) positivity in cervical cancer screening of women in a peri-urban area in Andhra Pradesh, India.

Vedantham H, Silver MI, Kalpana B, Rekha C, Karuna BP, Vidyadhari K, Mrudula S, Ronnett BM, Vijayaraghavan K, Ramakrishna G, Sowjanya P, Laxmi S, Shah KV, Gravitt PE; CATCH Study Team.

Cancer Epidemiol Biomarkers Prev. 2010 May;19(5):1373-80. doi: 10.1158/1055-9965.EPI-09-1282.

24.

Adult male circumcision: will it reduce disease caused by human papillomavirus?

Viscidi RP, Shah KV.

J Infect Dis. 2010 May 15;201(10):1447-9. doi: 10.1086/652186. No abstract available.

PMID:
20370482
25.

Can human papillomavirus DNA testing of self-collected vaginal samples compare with physician-collected cervical samples and cytology for cervical cancer screening in developing countries?

Bhatla N, Dar L, Patro AR, Kumar P, Kriplani A, Gulati A, Iyer VK, Mathur SR, Sreenivas V, Shah KV, Gravitt PE.

Cancer Epidemiol. 2009 Dec;33(6):446-50. doi: 10.1016/j.canep.2009.10.013. Epub 2009 Nov 20.

26.

Investigation of pre-diagnostic virological markers for progressive multifocal leukoencephalopathy in human immunodeficiency virus-infected patients.

Grabowski MK, Viscidi RP, Margolick JB, Jacobson LP, Shah KV.

J Med Virol. 2009 Jul;81(7):1140-50. doi: 10.1002/jmv.21493.

27.

Suitability of self-collected vaginal samples for cervical cancer screening in periurban villages in Andhra Pradesh, India.

Sowjanya AP, Paul P, Vedantham H, Ramakrishna G, Vidyadhari D, Vijayaraghavan K, Laksmi S, Sudula M, Ronnett BM, Das M, Shah KV, Gravitt PE; Community Access to Cervical Health Study Group.

Cancer Epidemiol Biomarkers Prev. 2009 May;18(5):1373-8. doi: 10.1158/1055-9965.EPI-08-1171.

28.

The Yb(2)Al(1-x)Mg(x)Si(2) series from a spin fluctuation (x = 0) to a magnetically ordered ground state (x = 1).

Shah KV, Bonville P, Manfrinetti P, Wrubl F, Dhar SK.

J Phys Condens Matter. 2009 Apr 29;21(17):176001. doi: 10.1088/0953-8984/21/17/176001. Epub 2009 Mar 24.

PMID:
21825437
29.

The effect of highly active antiretroviral therapy on human papillomavirus clearance and cervical cytology.

Paramsothy P, Jamieson DJ, Heilig CM, Schuman PC, Klein RS, Shah KV, Rompalo AM, Cu-Uvin S, Duerr A.

Obstet Gynecol. 2009 Jan;113(1):26-31. doi: 10.1097/AOG.0b013e31819225cb.

PMID:
19104356
30.

Asia Pacific: cervical cancer screening and human papillomavirus vaccination policy and delivery.

Shah KV.

Vaccine. 2008 Aug 19;26 Suppl 12:iii-iv. doi: 10.1016/j.vaccine.2008.06.033. No abstract available.

31.

Human papillomavirus-type distribution in women with and without cervical neoplasia in north India.

Bhatla N, Dar L, Rajkumar Patro A, Kumar P, Pati SK, Kriplani A, Gulati A, Broor S, Iyer VK, Mathur S, Shah KV, Gravitt PE.

Int J Gynecol Pathol. 2008 Jul;27(3):426-30. doi: 10.1097/PGP.0b013e31816085ba.

32.

CTLA-4 is a direct target of Wnt/beta-catenin signaling and is expressed in human melanoma tumors.

Shah KV, Chien AJ, Yee C, Moon RT.

J Invest Dermatol. 2008 Dec;128(12):2870-9. doi: 10.1038/jid.2008.170. Epub 2008 Jun 19.

33.

Determinants of incidence and clearance of high-risk human papillomavirus infections in rural Rakai, Uganda.

Safaeian M, Kiddugavu M, Gravitt PE, Gange SJ, Ssekasanvu J, Murokora D, Sklar M, Serwadda D, Wawer MJ, Shah KV, Gray R.

Cancer Epidemiol Biomarkers Prev. 2008 Jun;17(6):1300-7. doi: 10.1158/1055-9965.EPI-07-2678.

34.

Prevalence and risk factors for carcinogenic human papillomavirus infections in rural Rakai, Uganda.

Safaeian M, Kiddugavu M, Gravitt PE, Gange SJ, Ssekasanvu J, Murokora D, Sklar M, Serwadda D, Wawer MJ, Shah KV, Gray R.

Sex Transm Infect. 2008 Aug;84(4):306-11. doi: 10.1136/sti.2007.027318. Epub 2008 Apr 2.

PMID:
18385223
35.

Risk factors for cervical cancer among HPV positive women in Mexico.

Flores YN, Bishai DM, Shah KV, Lazcano-Ponce E, Lörincz A, Hernández M, Ferris D, Salmerón J.

Salud Publica Mex. 2008 Jan-Feb;50(1):49-58.

36.

Cancer. A skin cancer virus?

Viscidi RP, Shah KV.

Science. 2008 Feb 22;319(5866):1049-50. doi: 10.1126/science.1155048. No abstract available.

PMID:
18292327
37.

Evaluation of adjunctive tests for cervical cancer screening in low resource settings.

Bhatla N, Mukhopadhyay A, Kriplani A, Pandey RM, Gravitt PE, Shah KV, Iyer VK, Verma K.

Indian J Cancer. 2007 Apr-Jun;44(2):51-5.

39.

The Wnt5A/protein kinase C pathway mediates motility in melanoma cells via the inhibition of metastasis suppressors and initiation of an epithelial to mesenchymal transition.

Dissanayake SK, Wade M, Johnson CE, O'Connell MP, Leotlela PD, French AD, Shah KV, Hewitt KJ, Rosenthal DT, Indig FE, Jiang Y, Nickoloff BJ, Taub DD, Trent JM, Moon RT, Bittner M, Weeraratna AT.

J Biol Chem. 2007 Jun 8;282(23):17259-71. Epub 2007 Apr 10.

40.

Should human papillomavirus vaccination be mandatory?

Viscidi RP, Shah KV.

Virtual Mentor. 2007 Dec 1;9(12):823-6. doi: 10.1001/virtualmentor.2007.9.12.pfor1-0712. No abstract available.

41.

Empyema thoracis: a clinical study.

Acharya PR, Shah KV.

Ann Thorac Med. 2007 Jan;2(1):14-7. doi: 10.4103/1817-1737.30356.

42.

Lack of BK virus DNA sequences in most transitional-cell carcinomas of the bladder.

Rollison DE, Sexton WJ, Rodriguez AR, Kang LC, Daniel R, Shah KV.

Int J Cancer. 2007 Mar 15;120(6):1248-51.

43.

SV40 and human cancer: a review of recent data.

Shah KV.

Int J Cancer. 2007 Jan 15;120(2):215-23. Review.

44.

Comparability of self-collected vaginal swabs and physician-collected cervical swabs for detection of human papillomavirus infections in Rakai, Uganda.

Safaeian M, Kiddugavu M, Gravitt PE, Ssekasanvu J, Murokora D, Sklar M, Serwadda D, Wawer MJ, Shah KV, Gray R.

Sex Transm Dis. 2007 Jul;34(7):429-36.

PMID:
17075437
45.

Human papillomavirus type distribution in cervical cancer in Delhi, India.

Bhatla N, Dar L, Patro AR, Kriplani A, Gulati A, Verma K, Broor S, Shah KV, Gravitt PE.

Int J Gynecol Pathol. 2006 Oct;25(4):398-402.

PMID:
16990719
46.

Chapter 4: Burden and management of non-cancerous HPV-related conditions: HPV-6/11 disease.

Lacey CJ, Lowndes CM, Shah KV.

Vaccine. 2006 Aug 31;24 Suppl 3:S3/35-41. Review.

PMID:
16950016
47.

Smoking and time to clearance of human papillomavirus infection in HIV-seropositive and HIV-seronegative women.

Koshiol J, Schroeder J, Jamieson DJ, Marshall SW, Duerr A, Heilig CM, Shah KV, Klein RS, Cu-Uvin S, Schuman P, Celentano D, Smith JS.

Am J Epidemiol. 2006 Jul 15;164(2):176-83. Epub 2006 Jun 14.

PMID:
16775041
48.

Time to clearance of human papillomavirus infection by type and human immunodeficiency virus serostatus.

Koshiol JE, Schroeder JC, Jamieson DJ, Marshall SW, Duerr A, Heilig CM, Shah KV, Klein RS, Cu-Uvin S, Schuman P, Celentano D, Smith JS.

Int J Cancer. 2006 Oct 1;119(7):1623-9.

49.

Polyomaviruses and human diseases.

Ahsan N, Shah KV.

Adv Exp Med Biol. 2006;577:1-18. Review.

PMID:
16626024
50.

Prediagnostic circulating antibodies to JC and BK human polyomaviruses and risk of non-Hodgkin lymphoma.

Rollison DE, Engels EA, Halsey NA, Shah KV, Viscidi RP, Helzlsouer KJ.

Cancer Epidemiol Biomarkers Prev. 2006 Mar;15(3):543-50.

Supplemental Content

Support Center